Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,913 | 268.5 | 513,640 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,107 | 267.47 | 296,089 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 593 | 266.04 | 157,762 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 283.61 | 56,722 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 281.79 | 56,358 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 200 | 280.41 | 56,082 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,100 | 279.46 | 307,406 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 361 | 277.77 | 100,275 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 276.4 | 27,640 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 100 | 275.24 | 27,524 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 400 | 274.7 | 109,880 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 539 | 273.48 | 147,406 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,500 | 272.74 | 409,110 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 800 | 271.27 | 217,016 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 700 | 270.25 | 189,175 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 300 | 268.99 | 80,697 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 500 | 267.88 | 133,940 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)